Iluvatar CoreX has unveiled the allocation outcomes on the Hong Kong Stock Exchange. The Hong Kong public offering witnessed an overwhelming response, with subscriptions reaching a staggering 414.24 times the offered shares. Meanwhile, the international offering also garnered significant interest, achieving a subscription rate of 10.68 times. The company has officially set the issue price at HK$144.60 per share, with the total net proceeds from the offering amounting to HK$3,509.3 million. Share trading is scheduled to commence on the Hong Kong Stock Exchange on January 8, 2026.
